State Board Of Administration Of Florida Retirement System Adverum Biotechnologies, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.81 - $1.34 $25,323 - $41,893	-31,264 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$8.53 - $25.64 $65,715 - $197,530	7,704 Added 32.7%	31,264 $653,000
Q1 2020 May 05, 2020	BUY	$7.98 - $16.32 $30,403 - $62,179	3,810 Added 19.29%	23,560 $230,000
Q2 2019 Aug 05, 2019	BUY	$5.1 - $11.89 $19,737 - $46,014	3,870 Added 24.37%	19,750 $235,000
Q2 2018 Aug 06, 2018	BUY	$5.3 - $6.9 $84,164 - $109,572	15,880 New	15,880 $84,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$3.48 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$107,702
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$7,889
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account